Eni, Congo Sign MoU On Joint Development Of Bio-refining Agro-feedstock Sector

Eni (E), and Republic of Congo have signed a Memorandum of Understanding on the joint development of the agro-biofuel sector in the country. The MoU sets the framework for the industrial scale production of castor oil, to provide feedstock for the company's bio-refinery system, while also creating employment opportunities and expanding agricultural activities to marginal and abandoned lands. The pilot phase is set to begin this month. The industrial development phase is anticipated to see cultivations on 150,000 hectares with 90,000 estimated beneficiaries by 2030, the company said.

Separately, Eni said its CEO Claudio Descalzi has met with the President of Benin, Patrice Talon, to discuss a possible collaboration in the field of the energy transition and the circular economy. They discussed projects for the agro-industrial chain, focused on the valorization of agricultural waste and the production of oleaginous plants that do not inhibit food production, to be used in bio-refining.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT